OWC Pharmaceutical Research Corp (OWCP)

[retireearly1955]

On November 8, 2018, the Registrant was granted a Certificate of Patent, #2015101908 (the “Innovation Patent”) from the Commissioner of Patents, Commonwealth of Australia, for the Registrant’s proprietary cream for the treatment of skin disorders. The Registrant’s skin cream has been proven, pre-clinically, to lower various inflammatory markers by up to 70% and to inhibit Keratocytes proliferation, a manifestation of various skin disorders, especially Psoriasis. A human safety study for the OWC cream is currently ongoing. We believe that the Innovation Patent granted in Australia, valid for a term of 8 years, should be followed by additional patent grants in other jurisdictions and should afford protection and competitive advantage to the Registrant, subsequent to efficacy trials to be performed in 2018, to manufacture, distribute and sell our cannabis based products wherever there exists a lawful medical cannabis market.